This recognition underscores Massive Bio’s innovative contributions to revolutionizing cancer care through advanced artificial intelligence solutions. CB Insights’ market map highlights ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

SHANGHAI & INDIANAPOLIS--(BUSINESS WIRE)--Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development of innovative small-molecule therapies in oncology, today ...

The Phase 3 VERITAC-2 clinical trial (NCT05654623) is a global, randomized trial evaluating the efficacy and safety of vepdegestrant (ARV-471) as a monotherapy compared to fulvestrant in patients with ...

To introduce key concepts and techniques in chemical biology, including Synthesis of DNA, RNA and peptides To introduce key concepts and techniques in drug discovery. To discuss the methods used in ...

In June 2021, the Future Targeted Healthcare Manufacturing Hub held a workshop to discuss the application of a new point-of-care manufacturing regulatory framework in development by the UK’s ...

Through a series of talks and roundtable discussions, participants explored challenges of applying the regulatory framework to cell and gene therapies (also known as Advanced Therapy Medicinal ...